| Literature DB >> 35161227 |
Anees Ahmad1,2, Naseem Ahmad1, Mohammad Anis1, Mohammad Faisal3, Abdulrahman A Alatar3, Eslam M Abdel-Salam3, Ram Pratap Meena4, Iyyakkannu Sivanesan5.
Abstract
Trees are vital resources for economic, environmental, and industrial growth, supporting human life directly or indirectly through a wide variety of therapeutic compounds, commodities, and ecological services. Pterocarpus marsupium Roxb. (Fabaceae) is one of the most valuable multipurpose forest trees in India and Sri Lanka, as it is cultivated for quality wood as well as pharmaceutically bioactive compounds, especially from the stem bark and heartwood. However, propagation of the tree in natural conditions is difficult due to the low percentage of seed germination coupled with overexploitation of this species for its excellent multipurpose properties. This overexploitation has ultimately led to the inclusion of P. marsupium on the list of endangered plant species. However, recent developments in plant biotechnology may offer a solution to the overuse of such valuable species if such advances are accompanied by technology transfer in the developing world. Specifically, techniques in micropropagation, genetic manipulation, DNA barcoding, drug extraction, delivery, and targeting as well as standardization, are of substantial concern. To date, there are no comprehensive and detailed reviews of P. marsupium in terms of biotechnological research developments, specifically pharmacognosy, pharmacology, tissue culture, authentication of genuine species, and basic gene transfer studies. Thus, the present review attempts to present a comprehensive overview of the biotechnological studies centered on this species and some of the recent novel approaches for its genetic improvement.Entities:
Keywords: DNA barcoding; biotechnological tools; ethnomedicine; genetic improvement; in vitro culture
Year: 2022 PMID: 35161227 PMCID: PMC8839240 DOI: 10.3390/plants11030247
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Pterocarpus marsupium Roxb. (22°23′25″ N and 84°21′44″ E, Chhattisgarh state of India).
Important bioactive compounds extracted from Pterocarpus marsupium (in chronological order).
| Plant Parts | Extract | Technique * | Bioactive Compound | References |
|---|---|---|---|---|
| Heartwood | Ethyl acetate | C-SG | Pterostilbene ( | [ |
| Bark | Ethanolic extract | C-SG | (−)-Epicatechin ( | [ |
| Ethyl acetate | C-SG | Naringenin ( | [ | |
| Roots | Ethanolic extract | C-SG | 7-Hydroxy-6, 8-dimethyl flavanone-7- | [ |
| Heartwood | Ethyl acetate | Thin Layer Chromatography | Marsupsin ( | [ |
| Heartwood | Ethyl acetate | C-SG | Pterosupin ( | [ |
| Heartwood | Aqueous extract | C-SG | Pterocarposide ( | [ |
| Heartwood | Aqueous extract | Coulman chromatography over Sephadex LH-20 | 1-(2′,6′-Dihydroxyphenyl)-β-D-glucopyranoside ( | [ |
| Heartwood | Aqueous extract | C-SG | Pteroisoauroside ( | [ |
| Leaves | Methanolic extract | UV-spectrophotometer | Phenolics | [ |
| Wood and bark | Ethanolic extract | GC-MS | 3- | [ |
| Apical stem bark | Methanolic extract | Followed standard protocols | Alkaloids | [ |
| Heartwood | Ethanolic extract | C-SG | Pteroside ( | [ |
| Heartwood | Ethanolic extract | C-SG and HPLC | (+)-Dihydrorobinetin ( | [ |
| Heartwood | Methanolic extract | LC-MS-MS | Pterosupol | [ |
| Heartwood | Methanolic extract | HPLC and FTIR | Liquiritigenin | [ |
* Technique—Phytochemical compound identification techniques used, C-SG—Chromatography over Silica Gel, GC-MS—Gas Chromatography-Mass Spectrometry, LC-MS-MS—Liquid Chromatography with Tandem Mass Spectrometry, HPLC—High-Performance Liquid Chromatography, FTIR—Fourier Transform Infrared Spectroscopy.
Figure 2Molecular structure of bioactive compounds extracted from Pterocarpus marsupium Roxb.
Figure 3Molecular structure of bioactive compounds extracted from Pterocarpus marsupium Roxb.
Potential activities of some important bioactive compounds or aqueous extracts of Pterocarpus marsupium (in chronological order).
| S.N. | Extracts/Bioactive Compound | Potential Activities | References |
|---|---|---|---|
| 1 | (−)-Epicatechin ( | No effect on central nervous system | [ |
| 2 | Flavonoids | Anti-hyperlipidemic | [ |
| 3 | Phenolics | Anti-hyperglycemic | [ |
| 4 | Pterostilbene ( | Cyclooxygenase-2 (COX-2) inhibition | [ |
| 5 | Pterostilbene and 3,5-hydroxypterostilbene | Induce apoptosis in tumor cells | [ |
| 6 | 5,7,2-4 tetrahydroxy isoflavone 6-6 glucoside | Cardiotonic | [ |
| 7 | Pterostilbene | Anti-cancerous | [ |
| 8 | Phenolics | Anti-oxidant | [ |
| 9 | Pterostilbene | Anti-cancerous | [ |
| 10 | Bark extract | Anti-oxidant | [ |
| 11 | Extract of bark and wood | Anti-diabetic | [ |
| 12 | Extract of apical stem bark | Anti-microbicidal | [ |
| 13 | Phenolic- | Anti-diabetic | [ |
| 14 | Pterostilbene | Novel telomerase inhibitor | [ |
| 15 | Heartwood extract | Dipeptidyl peptidase-4 (DPP-4) inhibition activity | [ |
| 16 | Heartwood extract | Anti-glycation | [ |
| 17 | Pterostilbene | Inhibition of platelet aggregation | [ |
| 18 | Heartwood extract | Reduction in body weight | [ |
| 19 | (+)-Dihydrorobinetin ( | Radical scavenging activity | [ |
| 20 | Heartwood extract | In vitro lipid lowering activity | [ |
| 21 | Liquiritigenin ( | Hypoglycemic activity | [ |
| 22 | Pterostilbene | Sun (UV rays) protective capacity | [ |
Figure 4Different sources of explants (or planting materials) used for in vitro propagation of Pterocarpus marsupium Roxb. (A) Winged fruit, (B) 24 h presoaked seeds, (C) Intact seedling, (D) Shoot tip culture, (E) Juvenile nodal segment culture, (F) Cotyledonary node culture, (G) Cotyledonary leaf culture, (H) Hypocotyl segment culture, (I) Axenic seedling culture, (J) Callus culture via hypocotyl segment, (K) Synthetic seed culture, (L) Root culture, (M) Mature nodal segment culture.
In vitro propagation protocols for Pterocarpus marsupium (in chronological order).
| Explants | Source | Media Compositions | Culture Response | Media Compositions (Rhizogenesis) | Rooting Response | Plantlets Survival Rate | References |
|---|---|---|---|---|---|---|---|
| Shoot tip | AS/MT | MS + 0.2 mg·L−1 BAP | Ca-Dm | - | - | - | [ |
| Aseptic seeds | - | MS basal medium | ISG (95–100%) | - | - | >68% | [ |
| Nodal segment | 35-d-old-AS | MS + 0.2 mg·L−1 IBA | IO | MS + 0.2 mg·L−1 IBA | RF | ||
| Cotyledonary node | 20-d-old-AS | MS + 4.44 µM BA+ 0.26 µM NAA | SM (85%) | ½ MS + 9.84 µM IBA | RF (IVR) | 52% | [ |
| Cotyledonary node | 18-d-old-AS | MS + 5.0 µM BA + 0.25 µM IAA | SM (75%) | 2-step-method: | MRI (40–50%) | - | [ |
| FT on ½ MS (semi-solid) + 0.5 µM IBA | ER (IVR) | ||||||
| Aseptic seeds | - | ½ MS 0.25 mg·L−1 GA3 | ISG (80%) | - | - | - | [ |
| Cotyledonary node | 18-d-old-AS | 2-step-method: | MSI (90%) | 2-step-method: | MRI (65%) | 70% | [ |
| FT on SEM: MS + 5.0 µM BA | ES (90%) | FT on ½ MS + 0.5 µM IBA + 3.96 µM PG | ER (IVR) | ||||
| Nodal segment | 18-d-old-AS | MS + 4.0 µM BA + 0.5 µM IAA + 20 µM AdS | SM (85%) | 2-step-method: | MRI (70%) | 75% | [ |
| FT on ½ MS (semi-solid) + 0.5 µM IBA | ER (IVR) | ||||||
| Hypocotyl | 12-d-old-AS | MS + 5.0 µM 2,4-D + 1.0 µM BA | Ca-Fm (90%) | ½ MS + 1.0 µM BA | SEG (56%) | 60% | [ |
| MS + 0.5 µM BA + 0.1 µM NAA + 10 µM ABA | SEs (51%) | ||||||
| Aseptic seed | - | ½ MS basal medium | ISG (96%) | - | - | - | [ |
| Cotyledonary node | 18-d-old-AS | MS + 1.0 mg·L−1 BAP + 0.5 mg·L−1 NAA | SM (70%) | - | - | - | |
| Aseptic seed | - | ½ MS basal medium | ISG (78.23%) | - | - | - | [ |
| Immature zygotic embryo | Green fruits | MS + 3.0 mg·L−1 BA + 0.5 mg·L−1 IAA | SM (93.8%) | 2-step-method: | MRI (70.8%) | 74% | [ |
| FT on ½ MS basal medium | ER (IVR) | ||||||
| Immature cotyledon | 9-d-old-AS | 3-step-method: | Ca-Fm (60.41%) | 2-step-method: | 95% | [ | |
| FT on MS + 8.9 µM BAP + 1.07 µM NAA | MSI (60.41%) | PT on ½ MS (liquid) + 19.6 µM IBA | MRI (75%) | ||||
| FT on MS + 4.4 µM BAP | ES | FT on ½ MS + 2.85 µM IBA | ER (IVR) | ||||
| Nodal segment | 10-y-old-MT | 2-step-method: | MSBB (64.44%) | ½ MS + 4.92 µM IBA | RF (42%) | - | [ |
| FT on MS + 9.3 µM Kn + 0.54 µM NAA + 568 µM AA + 260 µM CA + 605 µM AmS + 217 µM AdS | ES | ||||||
| Nodal segment | 4-w-old-AS | 2-step-method: | MSBB (96%) | 2-step-method: | MRI (80%) | 75% | [ |
| FT on MS (semisolid) + 5.0 µM | ES (70%) | FT on ½ MS + 1.5 µM IBA | ER (IVR) | ||||
| Cotyledonary node | 20-d-old-AS | MS + 7.5 µM | SM (85%) | 2-step-method: | MRI (75%) | 80% | [ |
| FT on ½ MS + 1.0 µM IBA | ER (IVR) | ||||||
| Immature zygotic embryo | Green fruits | MS + 5.37 µM NAA | SEs (67.3%) | ½ MS + 5.8 µM GA3 | SEG (70%) | 78% | [ |
| MS + 2.69 µM NAA + 4.4 µM BA + 3% Sucrose | |||||||
| Shoot tip | 7-d-old-AS | MS + 7.0 µM | SM (80%) | 2-step-method: | MRI (67.7%) | 96.7% | [ |
| FT on Soilrite | ER (EVR) | ||||||
| In vitro seedling | Seed | MS + 0.5 µM GA3 + 0.5 µM TDZ | SM (85%) | 2-step-method: | MRI (80%) | 86.7% | [ |
| FT on ½ MS + 0.5 µM GA3 | ER (IVR) | ||||||
| Aseptic seeds | - | ½ MS 0.5 µM GA3 | ISG (91.3%) | - | - | - | [ |
* AA—Ascorbic acid, ABA—Abscisic acid, AdS—Adenine sulphate, AmS—Ammonium sulphate, AS—Axenic seedling, BA—6-benzyladenine, CA—Citric acid, Ca-Dm—Callus-dead mass, Ca-Fm—Callus-fresh mass, d—days, ER—Elongation of roots, ES—Elongation of shoots, EVR—Ex vitro rooting, FT—Followed to transfer, GA3—Gibberellic acid, h—hours, IBA—Indole-3-butyric acid, IO—Indirect organogenesis, IVR—In vitro rooting, ISG—In vitro seed germination, Kn—Kinetin, MRI—Multiple root induction, MSBB—Multiple shoot bud break, MSI—Multiple shoot induction, MT—Mature tree, mT—Meta-topolin, NAA—α-naphthalene acetic acid, PG—Phloroglucinol, PT—Pretreatment, RF—Root formation, SEG—Somatic embryos germination, SEM—Shoot elongation medium, SEs—Somatic embryos, SIM—Shoot induction medium, SM—Shoot multiplication, TB—1,2,3-trihydroxy benzene, TDZ—Thidiazuron, w—week, y—year, 2,4-D—2,4-dichlorophenoxyacetic acid.
Figure 5Comparative molecular structure of 6-benzyladenine (BA) and meta-topolin (mT).
Figure 6In vitro shoot morphogenesis in Pterocarpus marsupium Roxb. (A) Multiple shoots on MS + 0.5 μM TDZ, after 3 weeks. (B) Multiplication on MS + 5.0 μM mT, after 6 weeks. (C) Multiple shoots proliferation on MS + 0.5 μM GA3 + 0.5 μM TDZ + 1.0 μM NAA, after 9 weeks.
Figure 7Two step rooting strategy for root formation in microshoots of Pterocarpus marsupium Roxb. (A) Pretreatment of microshoot in liquid medium employing filter paper bridge; (B) Pretreated microshoot transferred onto semi-solid medium containing phytagel for in vitro root formation; (C) 4-week-old in vitro rooted microshoot; (D) Pretreated microshoot transferred onto Soilrite (a synthetic soil) for ex vitro root formation; (E) 4-week-old ex vitro rooted microshoot; (F) Acclimatized plantlet in Soilrite.